Prakash Chinnaiyan
Expertise in
21
conditions

Dr. Prakash Chinnaiyan

Radiation Oncology
3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
Accepting New Patients
Referral may be required
Before you request
Expertise in
21
conditions
3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 

Overview

Prakash Chinnaiyan is a Radiation Oncologist practicing medicine in Royal Oak, Michigan.

Dr. Chinnaiyan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery.

Dr. Chinnaiyan is board certified in American Board Of Radiology. He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 2 clinical trials. Dr. Chinnaiyan is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Therapeutic Radiology in WI

Board Certifications

American Board Of Radiology

Hospital Affiliations

Corewell Health Trenton Hospital
Corewell Health Beaumont Grosse Pointe Hospital
Corewell Health Taylor Hospital
Corewell Health William Beaumont University Hospital
Corewell Health Beaumont Troy Hospital
Corewell Health Wayne Hospital
Corewell Health Dearborn Hospital
Beaumont Hospital, Troy
Beaumont Hospital Royal Oak

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 10 Less Insurance Carriers -

Locations

Rose Cancer Treatment Center
3577 West 13 Mile Road, Suite Ll, Royal Oak, MI 48073

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Phase 1 Study of TPI 287 Concurrent With Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases From Advanced Breast and Non-Small Cell Lung (NSCL) Cancer
A Phase 1 Study of TPI 287 Concurrent With Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases From Advanced Breast and Non-Small Cell Lung (NSCL) Cancer
Enrollment Status: Terminated
Publish Date: February 04, 2021
Intervention Type: Drug, Procedure
Study Phase: Phase 1
View 1 Less Clinical Trial

52 Total Publications

Enhanced lipid metabolism serves as a metabolic vulnerability to a polyunsaturated fatty acid (PUFA)-rich diet in glioblastoma.
Enhanced lipid metabolism serves as a metabolic vulnerability to a polyunsaturated fatty acid (PUFA)-rich diet in glioblastoma.
Journal: Research square
Published: July 18, 2025
Similar Doctors
Expertise in
41
conditions
Dr. Inga S. Grills
Radiation Oncology
Expertise in
41
conditions
Dr. Inga S. Grills
Radiation Oncology
Referral may be required
Before you request

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
 (0.1 miles away)
248-551-5490
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Inga Grills is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Grills is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery. Dr. Grills is board certified in American Board Of Radiology. Dr. Grills is currently accepting new patients.

Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Referral may be required

University Hospital

1500 E Medical Center Dr, Floor B2 C490, 
Ann Arbor, MI 
 (31.8 miles away)
734-936-4300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wahl is currently accepting new patients.

Expertise in
14
conditions
Dr. Mohamed A. Elshaikh
Radiation Oncology
Expertise in
14
conditions
Dr. Mohamed A. Elshaikh
Radiation Oncology
Referral may be required

Henry Ford Cancer-Detroit

2800 W Grand Blvd, 
Detroit, MI 
 (11.9 miles away)
888-777-4167
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mohamed Elshaikh is a Radiation Oncologist practicing medicine in Detroit, Michigan. Dr. Elshaikh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Prostate Cancer, Cervical Cancer, Familial Prostate Cancer, and Lymphadenectomy. Dr. Elshaikh is currently accepting new patients.

Frequently Asked Questions about Dr. Prakash Chinnaiyan

How do I make an appointment with Dr. Prakash Chinnaiyan?

You can book an appointment with Dr. Prakash Chinnaiyan by calling their office at 248-551-5490. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Prakash Chinnaiyan a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Prakash Chinnaiyan is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Prakash Chinnaiyan specialize in?

While Dr. Prakash Chinnaiyan is a Radiation Oncology, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Prakash Chinnaiyan participate in research or clinical trials?

Yes. Dr. Prakash Chinnaiyan has published 52 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Prakash Chinnaiyan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Prakash Chinnaiyan accept my insurance?

Dr. Prakash Chinnaiyan accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 248-551-5490 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chinnaiyan's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 9 Advanced Conditions
View All 78 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile